Viewing StudyNCT05869669



Ignite Creation Date: 2024-05-06 @ 7:00 PM
Last Modification Date: 2024-10-26 @ 2:59 PM
Study NCT ID: NCT05869669
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-04
First Post: 2023-04-12

Brief Title: RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
Sponsor: EIP Pharma Inc
Organization: EIP Pharma Inc

Organization Data

Organization: EIP Pharma Inc
Class: INDUSTRY
Study ID: EIP21-NFD-504
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: EIP Pharma Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
CervoMed Inc UNKNOWN
National Institute on Aging NIA NIH
Worldwide Clinical Trials OTHER